Clincosm LogoSign in Get a demo

lung squamous cell carcinoma

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

Recruiting
  • Lung Squamous Cell Carcinoma
  • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
  • Yancheng, Jiangsu, China
    Yancheng Clinical College of Xuzhou Medical University
Mar 21, 2023

ctDNA Testing Plus AI-based Pathology in Resectable LSCC

Recruiting
  • Lung Squamous Cell Carcinoma
  • WES and ctDNA detection
  • Changsha, Hunan, China
    Department of Thoracic Surgery, Second Xiangya Hospital of Centr
Mar 18, 2023

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Lung Squamous Cell Carcinoma, Neoadjuvant Therapy, Immunotherapy Trial in Hangzhou (Tislelizumab)

Recruiting
  • Lung Squamous Cell Carcinoma
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of med
Aug 22, 2021

Identify Prognostic Biomarkers of Lung Cancer

Recruiting
  • Lung Cancer
  • +3 more
    • Shanghai, China
      Renji Hospital, Shanghai Jiaotong University school of medicine
    Aug 14, 2021

    Lung Squamous Cell Carcinoma Trial in Shanghai (Afatinib)

    Unknown status
    • Lung Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Oct 25, 2019

    Lung Squamous Cell Carcinoma Trial (Apatinib)

    Unknown status
    • Lung Squamous Cell Carcinoma
    • (no location specified)
    Oct 30, 2018

    Head and Neck Squamous Cell Carcinoma, Anal Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma Trial in United States

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • +6 more
    • Sacramento, California
    • +12 more
    Jun 22, 2017

    Lung Squamous Cell Carcinoma Trial in Shanghai (CAR-GPC3 T Cells, Fludarabine, Cyclophosphamide)

    Unknown status
    • Lung Squamous Cell Carcinoma
    • CAR-GPC3 T Cells
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital,Shanghai Jiaotong University
    Aug 23, 2016